Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$848M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$631M |
| 3 |
Truist Financial
TFC
|
+$445M |
| 4 |
Amazon
AMZN
|
+$334M |
| 5 |
ServiceNow
NOW
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$466M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$139M |
| 4 |
Oracle
ORCL
|
+$136M |
| 5 |
Intuitive Surgical
ISRG
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Financials | 15.45% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Ducommun
DCO
$3.04B
| $7.33M | ﹤0.01% |
145,129
+4,766
| +3% | +$219K |
|
2202
Argan
AGX
$8.02B
| $7.32M | ﹤0.01% |
182,368
+16,304
| +10% | +$627K |
|
2203
GameStop
GME
$8.32B
| $7.3M | ﹤0.01% |
4,805,912
-70,688
| -1% | -$104K |
|
2204
Amneal Pharmaceuticals
AMRX
$6.15B
| $7.29M | ﹤0.01% |
1,513,322
+295,959
| +24% | +$1.03M |
|
2205
TherapeuticsMD
TXMD
$24.1M
| $7.29M | ﹤0.01% |
60,269
+6,171
| +11% | +$887K |
|
2206
Viking Therapeutics
VKTX
$3.97B
| $7.29M | ﹤0.01% |
908,515
+120,664
| +15% | +$880K |
|
2207
Virgin Galactic
SPCE
$500M
| $7.26M | ﹤0.01% |
+31,455
| New | +$6.14M |
|
2208
Live Oak Bancshares
LOB
$1.98B
| $7.26M | ﹤0.01% |
381,827
+17,540
| +5% | +$324K |
|
|
QADA
2209
DELISTED
QAD Inc.
QADA
| $7.21M | ﹤0.01% |
141,634
+9,360
| +7% | +$448K |
|
2210
Antero Resources
AR
$11.5B
| $7.21M | ﹤0.01% |
2,528,136
+89,555
| +4% | +$229K |
|
2211
Levi Strauss
LEVI
$8.64B
| $7.2M | ﹤0.01% |
373,312
+61,468
| +20% | +$1.1M |
|
2212
Arrow Financial
AROW
$725M
| $7.2M | ﹤0.01% |
214,346
+6,790
| +3% | +$214K |
|
2213
Cooper-Standard Automotive
CPS
$490M
| $7.17M | ﹤0.01% |
216,342
+7,257
| +3% | +$235K |
|
2214
Kura Oncology
KURA
$882M
| $7.15M | ﹤0.01% |
520,142
+21,110
| +4% | +$313K |
|
|
HONE
2215
DELISTED
HarborOne Bancorp
HONE
| $7.13M | ﹤0.01% |
648,392
+5,081
| +0.8% | +$53.3K |
|
|
WMC
2216
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $7.12M | ﹤0.01% |
68,963
+3,175
| +5% | +$322K |
|
|
SPTN
2217
DELISTED
SpartanNash
SPTN
| $7.12M | ﹤0.01% |
499,885
+13,036
| +3% | +$172K |
|
|
BDSI
2218
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $7.11M | ﹤0.01% |
1,124,954
+122,110
| +12% | +$718K |
|
2219
Option Care Health
OPCH
$3.57B
| $7.1M | ﹤0.01% |
475,607
+50,426
| +12% | +$682K |
|
|
WSR
2220
DELISTED
Whitestone REIT
WSR
| $7.05M | ﹤0.01% |
517,737
+24,157
| +5% | +$332K |
|
|
FRTA
2221
DELISTED
Forterra, Inc
FRTA
| $7.05M | ﹤0.01% |
609,910
+346,564
| +132% | +$3.37M |
|
2222
Carter Bankshares
CARE
$749M
| $7.04M | ﹤0.01% |
296,879
+22,828
| +8% | +$472K |
|
|
EIDX
2223
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $7.02M | ﹤0.01% |
122,305
+2,237
| +2% | +$111K |
|
2224
Alector
ALEC
$240M
| $7.02M | ﹤0.01% |
407,356
+35,115
| +9% | +$597K |
|
2225
Adtran
ADTN
$665M
| $7.01M | ﹤0.01% |
708,940
+43,964
| +7% | +$419K |
|
Similar funds
Geode Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Geode Capital Management held 4,322 positions worth $478B, up 12% from $428B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Geode Capital Management's Q4 2019 filing shows 132 new, 3,091 increased, 523 reduced and 113 closed positions. Its largest new stake was Apollo Global Management: 1,482,213 shares worth $70.7M. The largest sale was Celgene Corp, an estimated $1.15B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2019 buy was Apollo Global Management: 1,482,213 shares worth $70.7M.
- Geode Capital Management added most to Microsoft in Q4 2019, an estimated $848M increase.
- Geode Capital Management's biggest Q4 2019 reduction was Oracle, cutting an estimated $136M.
- Geode Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.15B.
- Geode Capital Management's ten largest holdings make up 19% of its $478B portfolio in Q4 2019.
- Geode Capital Management opened 132 new positions and closed 113 in Q4 2019.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $478B.
Based on Geode Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.